![Dane Saglio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dane Saglio
Geen lopende functies
Profiel
Dane R.
Saglio formerly worked at Public Communications Associates, as Director-Finance from 1996 to 2000, RegeneRx Biopharmaceuticals, Inc., as Chief Financial Officer from 2011 to 2014, Bresler & Reiner, Inc., as Comptroller, Sterling Software, Inc., as Accounting Manager from 1985 to 1988, CASI Pharmaceuticals, Inc., as Chief Financial Officer from 2000 to 2008, Helomics Corp., as Chief Financial Officer from 2014 to 2017, Seneca Biopharma, Inc., as Chief Executive & Financial Officer in 2021, New Generation Biofuels Holdings, Inc., as Chief Financial Officer & Secretary from 2010 to 2011, Celios Corp., as Chief Financial Officer from 2017 to 2019, and BullFrog AI Holdings, Inc., as Chief Financial Officer from 2021 to 2024.
Mr. Saglio received his undergraduate degree from the University of Maryland.
Eerdere bekende functies van Dane Saglio
| Bedrijven | Functie | Einde |
|---|---|---|
| BULLFROG AI HOLDINGS, INC. | Financieel Directeur/CFO | 07-12-2024 |
| PALISADE BIO, INC. | Algemeen Directeur | 27-04-2021 |
Celios Corp.
 Celios Corp. Electronics/AppliancesConsumer Durables Develops and commercializes advanced air technologies and purification equipment | Financieel Directeur/CFO | 01-07-2019 |
Helomics Corp.
 Helomics Corp. Medical/Nursing ServicesHealth Services Provides cancer care development and treatment consulting services | Financieel Directeur/CFO | 01-07-2017 |
| REGENERX BIOPHARMACEUTICALS, INC. | Financieel Directeur/CFO | 31-10-2014 |
Opleiding van Dane Saglio
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
42
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
RegeneRx Biopharmaceuticals, Inc.
 RegeneRx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and markets novel therapeutic peptide for tissue and organ protection, repair & regeneration | Health Technology |
Bresler & Reiner, Inc.
 Bresler & Reiner, Inc. Real Estate DevelopmentFinance Owns and develops real estate | Finance |
Sterling Software, Inc.
 Sterling Software, Inc. Packaged SoftwareTechnology Services Designs, develops, markets, licenses and supports standardized computer software products | Technology Services |
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for treating cancer and inflammatory diseases | Health Technology |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Helomics Corp.
Helomics Corp. Medical/Nursing ServicesHealth Services Provides cancer care development and treatment consulting services | Health Services |
Seneca Biopharma, Inc.
 Seneca Biopharma, Inc. BiotechnologyHealth Technology Manufactures biotherapeutic products | Health Technology |
New Generation Biofuels Holdings, Inc.
 New Generation Biofuels Holdings, Inc. Chemicals: SpecialtyProcess Industries Owns and leases a proprietary technology to manufacture bio-fuel | Process Industries |
Public Communications Associates | |
Celios Corp.
Celios Corp. Electronics/AppliancesConsumer Durables Develops and commercializes advanced air technologies and purification equipment | Consumer Durables |
BullFrog AI Holdings, Inc.
 BullFrog AI Holdings, Inc. Packaged SoftwareTechnology Services Develops an artificial intelligence and machine learning platform for clinical and pharmaceutical industry | Technology Services |
